OBJECTIVE: To identify the clinical pathological characteristics and prognostic factors in @entity1 with @entity674 of the stomach. METHODS: The data of 98 @entity1 of gastric @entity5 , @entity2909 , @entity1822 , @entity11004 , @entity808 and @entity3292 , collected from Mar. 1983 to Dec. 2001 in our hospital with complete clinical and pathological data, were investigated retrospectively. @entity356 were diagnosed by reviewing the @entity5 slides stained with @entity1710 and @entity1711 (H_E). Two histomorphologically representative areas of each @entity5 slides were identified and arrayed on a tissue microarray. Immunohistochemistry staining were performed using antibodies to @entity2467 ( @entity2467 ), @entity2280 , smooth muscle actin (SMA), @entity2283 and @entity4483 proteins. The relations of various clinicopathologic characteristics and outcomes were tested by univariate analysis and multivariate analysis. RESULTS: Ninety-one @entity1 were clearly identified as gastric @entity5 from the 98 @entity1 , who were diagnosed as gastric @entity5 , @entity2909 , @entity1822 , @entity11004 schwannoma and @entity3292 (92.9%). The follow-up rate was 91% and the median follow up time was 54 months. The @entity1 survival rates at 1, 5 and 10 years were 88.8%, 79.6% and 63.7% respectively. Univariate analysis showed that @entity5 size, mitotic count, @entity5 @entity39 , nuclear pleomorphism, cell type, cell density, surgical procedure, @entity33 , age and lable index of Ki-67 were associated with prognosis (P<0.05). Multivariate analysis showed that @entity5 size, mitotic count, @entity33 and @entity5 @entity39 were predictors of prognosis (P<0.05). CONCLUSION: Tumor size of >10 cm, mitotic count of >10 mitoses per 50 high power fields, @entity39 and @entity33 are often associated with an aggressive clinical course in gastric @entity5 .

[Analysis of prognostic and clinicopathologic factors in XXXX of the stomach].

@entity1 :: ('9606', 'Species') :: ['patient', 'patients'] @entity808 :: ('MESH:D009442', 'Disease') :: ['schwannomas'] @entity2283 :: ('1674', 'Gene') :: ['Desmin'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis'] @entity5 :: ('MESH:D009369', 'Disease') :: ['stromal tumor', 'tumor', 'stromal tumors'] @entity1711 :: ('MESH:D004801', 'Chemical') :: ['eosin'] @entity3292 :: ('MESH:D009455', 'Disease') :: ['neurofibromas', 'neurofibroma'] @entity33 :: ('MESH:D052016', 'Disease') :: ['mucosal invasion'] @entity4483 :: ('6285', 'Gene') :: ['S-100'] @entity2467 :: ('3815', 'Gene') :: ['CD117', 'c-kit'] @entity1822 :: ('MESH:D007890', 'Disease') :: ['leiomyosarcoma', 'leiomyosarcomas'] @entity1710 :: ('MESH:D006416', 'Chemical') :: ['hematoxylin'] @entity674 :: ('MESH:D046152', 'Disease') :: ['gastrointestinal stromal tumors'] @entity11004 :: ('MESH:D018230', 'Disease') :: ['leiomyoblastomas', 'leiomyoblastoma'] @entity2280 :: ('947', 'Gene') :: ['CD34'] @entity2909 :: ('MESH:D007889', 'Disease') :: ['leiomyoma', 'leiomyomas'] @entity356 :: ('MESH:D013274', 'Disease') :: ['Gastric stromal tumors']
@entity674 :: (MESH:D046152,Disease) :: ['gastrointestinal stromal tumors']
